These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20651942)

  • 1. c-myc and N-myc promote active stem cell metabolism and cycling as architects of the developing brain.
    Wey A; Knoepfler PS
    Oncotarget; 2010 Jun; 1(2):120-30. PubMed ID: 20651942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c- and N-myc regulate neural precursor cell fate, cell cycle, and metabolism to direct cerebellar development.
    Wey A; Martinez Cerdeno V; Pleasure D; Knoepfler PS
    Cerebellum; 2010 Dec; 9(4):537-47. PubMed ID: 20658325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissection of the MYCN locus in Feingold syndrome and isolated oesophageal atresia.
    Cognet M; Nougayrede A; Malan V; Callier P; Cretolle C; Faivre L; Genevieve D; Goldenberg A; Heron D; Mercier S; Philip N; Sigaudy S; Verloes A; Sarnacki S; Munnich A; Vekemans M; Lyonnet S; Etchevers H; Amiel J; de Pontual L
    Eur J Hum Genet; 2011 May; 19(5):602-6. PubMed ID: 21224895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b.
    Cotterman R; Knoepfler PS
    PLoS One; 2009 Jun; 4(6):e5799. PubMed ID: 19495417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Myc and GCN5 regulate significantly overlapping transcriptional programs in neural stem cells.
    Martínez-Cerdeño V; Lemen JM; Chan V; Wey A; Lin W; Dent SR; Knoepfler PS
    PLoS One; 2012; 7(6):e39456. PubMed ID: 22745758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline deletion of the miR-17∼92 cluster causes skeletal and growth defects in humans.
    de Pontual L; Yao E; Callier P; Faivre L; Drouin V; Cariou S; Van Haeringen A; Geneviève D; Goldenberg A; Oufadem M; Manouvrier S; Munnich A; Vidigal JA; Vekemans M; Lyonnet S; Henrion-Caude A; Ventura A; Amiel J
    Nat Genet; 2011 Sep; 43(10):1026-30. PubMed ID: 21892160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GENETIC COUNSELLING IN FEINGOLD SYNDROME AND A NOVEL MUTATION.
    Atik T; Güvenç MS; Onay H; Özkinay F; Çoğulu Ö
    Genet Couns; 2016; 27(3):381-384. PubMed ID: 30204967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gain-of-function MYCN causes a megalencephaly-polydactyly syndrome manifesting mirror phenotypes of Feingold syndrome.
    Nishio Y; Kato K; Tran Mau-Them F; Futagawa H; Quélin C; Masuda S; Vitobello A; Otsuji S; Shawki HH; Oishi H; Thauvin-Robinet C; Takenouchi T; Kosaki K; Takahashi Y; Saitoh S
    HGG Adv; 2023 Oct; 4(4):100238. PubMed ID: 37710961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models.
    Mirzamohammadi F; Kozlova A; Papaioannou G; Paltrinieri E; Ayturk UM; Kobayashi T
    Nat Commun; 2018 Apr; 9(1):1352. PubMed ID: 29636449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel MYCN Variant Associated with Intellectual Disability Regulates Neuronal Development.
    Yu X; Hu L; Liu X; Zhan G; Mei M; Wang H; Zhang X; Qiu Z; Zhou W; Yang L
    Neurosci Bull; 2018 Oct; 34(5):854-858. PubMed ID: 29786759
    [No Abstract]   [Full Text] [Related]  

  • 11. SIRT1 regulates sphingolipid metabolism and neural differentiation of mouse embryonic stem cells through c-Myc-SMPDL3B.
    Fan W; Tang S; Fan X; Fang Y; Xu X; Li L; Xu J; Li JL; Wang Z; Li X
    Elife; 2021 May; 10():. PubMed ID: 34042046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain.
    Zhao X; D' Arca D; Lim WK; Brahmachary M; Carro MS; Ludwig T; Cardo CC; Guillemot F; Aldape K; Califano A; Iavarone A; Lasorella A
    Dev Cell; 2009 Aug; 17(2):210-21. PubMed ID: 19686682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular characterizations of 11 new patients with type 1 Feingold syndrome: Proposal for selecting diagnostic criteria and further genetic testing in patients with severe phenotype.
    Tedesco MG; Lonardo F; Ceccarini C; Cesarano C; Digilio MC; Magliozzi M; Rogaia D; Mencarelli A; Leoni C; Piscopo C; Imperatore V; Falco MT; Fontana P; Nardone AM; Novelli A; Troiani S; Seri M; Prontera P
    Am J Med Genet A; 2021 Apr; 185(4):1204-1210. PubMed ID: 33442900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association esophageal atresia type 3 - microcephaly: an incomplete Feingold syndrome?].
    Shongo MY; Lubala TK; Mbuyi SM; Makinko PI; Ngwej DT; Kabange FN
    Pan Afr Med J; 2012; 13():85. PubMed ID: 23396887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurobehavioral Alterations in a Genetic Murine Model of Feingold Syndrome 2.
    Fiori E; Babicola L; Andolina D; Coassin A; Pascucci T; Patella L; Han YC; Ventura A; Ventura R
    Behav Genet; 2015 Sep; 45(5):547-59. PubMed ID: 26026879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation in MYCN gene causing congenital absence of the flexor pollicis longus tendon as an unusual presentation of Feingold syndrome 1.
    Peleg A; Kurolap A; Sagi-Dain L; Larom-Khan G; Adir V; Mory A; Paperna T; Shuldiner AR; Gonzaga-Jauregui C; Adir N; Baris Feldman H; Wollstein R
    Clin Dysmorphol; 2021 Apr; 30(2):71-75. PubMed ID: 32925198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. myc maintains embryonic stem cell pluripotency and self-renewal.
    Varlakhanova NV; Cotterman RF; deVries WN; Morgan J; Donahue LR; Murray S; Knowles BB; Knoepfler PS
    Differentiation; 2010 Jul; 80(1):9-19. PubMed ID: 20537458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nestin is a potential mediator of malignancy in human neuroblastoma cells.
    Thomas SK; Messam CA; Spengler BA; Biedler JL; Ross RA
    J Biol Chem; 2004 Jul; 279(27):27994-9. PubMed ID: 15117961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features of Feingold syndrome 1 dominate in subjects with 2p deletions including MYCN.
    Burnside RD; Molinari S; Botti C; Brooks SS; Chung WK; Mehta L; Schwartz S; Papenhausen P
    Am J Med Genet A; 2018 Sep; 176(9):1956-1963. PubMed ID: 30088856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.
    Aravalli RN; Talbot NC; Steer CJ
    World J Gastroenterol; 2015 Feb; 21(7):2011-29. PubMed ID: 25717234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.